Literature DB >> 9339501

New advances in endovascular technology.

J C Palmaz1.   

Abstract

Future research on and development of intravascular stents, stent grafts, and other implantable devices will be aimed largely at improving their blood and tissue biocompatibility. Most of the modifications resulting from this research and development will alter the surface properties we currently understand: surface energy or "wetability," electrical surface charge, surface texture, and surface chemistry. However, as knowledge of the physical, chemical, and biological properties of bioprosthetic surface materials expands, new areas for exploration will develop, increasing the opportunities for improvement.

Mesh:

Year:  1997        PMID: 9339501      PMCID: PMC325436     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  17 in total

1.  Investigation of three-surface properties of several metals and their relation to blood compatibility.

Authors:  V A DePalma; R E Baier; J W Ford; V L Glott; A Furuse
Journal:  J Biomed Mater Res       Date:  1972

2.  Benestent II: back to the future.

Authors:  H Emanuelsson; W J van der Giessen; P W Serruys
Journal:  J Interv Cardiol       Date:  1994-12       Impact factor: 2.279

3.  Conformation of human plasma proteins at polymer surfaces: the effectiveness of surface heparinization.

Authors:  R Barbucci; A Magnani
Journal:  Biomaterials       Date:  1994-10       Impact factor: 12.479

4.  On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.

Authors:  G Elgue; M Blombäck; P Olsson; J Riesenfeld
Journal:  Thromb Haemost       Date:  1993-08-02       Impact factor: 5.249

5.  Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model.

Authors:  C Chen; A B Lumsden; J C Ofenloch; B Noe; E J Campbell; P W Stratford; Y P Yianni; A S Taylor; S R Hanson
Journal:  Ann Vasc Surg       Date:  1997-01       Impact factor: 1.466

6.  Seeding of intravascular stents with genetically engineered endothelial cells.

Authors:  D A Dichek; R F Neville; J A Zwiebel; S M Freeman; M B Leon; W F Anderson
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

7.  Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.

Authors:  W J van der Giessen; A M Lincoff; R S Schwartz; H M van Beusekom; P W Serruys; D R Holmes; S G Ellis; E J Topol
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

8.  Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study.

Authors:  P W Serruys; H Emanuelsson; W van der Giessen; A C Lunn; F Kiemeney; C Macaya; W Rutsch; G Heyndrickx; H Suryapranata; V Legrand; J J Goy; P Materne; H Bonnier; M C Morice; J Fajadet; J Belardi; A Colombo; E Garcia; P Ruygrok; P de Jaegere; M A Morel
Journal:  Circulation       Date:  1996-02-01       Impact factor: 29.690

9.  Hydrophilic surface modification of metallic endoluminal stents.

Authors:  J M Seeger; M D Ingegno; E Bigatan; N Klingman; D Amery; C Widenhouse; E P Goldberg
Journal:  J Vasc Surg       Date:  1995-09       Impact factor: 4.268

10.  Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.

Authors:  A Colombo; P Hall; S Nakamura; Y Almagor; L Maiello; G Martini; A Gaglione; S L Goldberg; J M Tobis
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

View more
  2 in total

1.  The influence of passivation and electropolishing on the performance of medical grade stainless steels in static and fatigue loading.

Authors:  L M Weldon; P E McHugh; W Carroll; E Costello; C O'Bradaigh
Journal:  J Mater Sci Mater Med       Date:  2005-02       Impact factor: 3.896

2.  In vitro hemocompatibility of thin film nitinol in stenotic flow conditions.

Authors:  C P Kealey; S A Whelan; Y J Chun; C H Soojung; A W Tulloch; K P Mohanchandra; D Di Carlo; D S Levi; G P Carman; D A Rigberg
Journal:  Biomaterials       Date:  2010-12       Impact factor: 12.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.